申请人:Sunovion Pharmaceuticals Inc.
公开号:US11077090B2
公开(公告)日:2021-08-03
Compounds of formula I:
are disclosed, as are pharmaceutical compositions containing such compounds. Methods of treating neurological or psychiatric diseases and disorders in a subject in need thereof are also disclosed.
式 I 的化合物:
以及含有此类化合物的药物组合物。还公开了治疗有需要的对象的神经或精神疾病和失调的方法。